Global Statistics

spot_img

Conference Coverage

ASH

Orna Therapeutics to Present Study Results Supporting its in vivo CAR Programs for Autoimmune Diseases

Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced upcoming presentations at the 67th American Society...
Danielle Garcia -
Conference Coverage

Lupus Foundation Showcases Research at 2025 Annual Meeting of the American College of Rheumatology

The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology...
Danielle Garcia -
Conference Coverage

First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases

AbelZeta Pharma, a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic products, today announced that clinical data...
Danielle Garcia -
Conference Coverage

STAR-101 Study results Highlighted at the 17th International Mesothelioma Interest Group (iMig) 2025

Results from the first-in-humans (FIH) STAR-101 clinical study (NCT05568680), an ongoing, open-label multicenter Phase 1 clinical trial designed to evaluate the safety, feasibility, and...
Peter Hofland -
Conference Coverage

HaemaLogiX Presents Updates on Novel Therapeutic Targets

During the 22nd International Myeloma Society (IMS) Annual Meeting & Exposition, held 14 – 17 September 14 17 2025 in Toronto, Canada, HaemaLogiX, a...
Danielle Garcia -
Conference Coverage

Preliminary Clinical Data of Allogeneic CD19/CD20 CAR T-Cell Therapy Shows Promisse in Mantle Cell Lymphoma

During the 19th National Conference on Hematology of the Chinese Medical Association held in Beijing, China, held in September 2015, Professor Xiaoxi Zhou, MD,...
Danielle Garcia -
123Page 2 of 3

Recent Articles

Stay on op - Ge the daily news in your inbox

spot_img

The Journal of CAR T-Cell Therapy is an international science & medicine-focused news publication designed to serve the needs of a diverse community, including academia, life sciences, pharma, clinical research, clinicians, and physicians. Along with global clinical and regulatory news, we also cover payor and policy-related news and updates.

© Copyright 2025, 2026 Sunvalley Communication, LLC and AAMEI®, American Association for Medical Education and Information - All Rights Reserved.

Quick Links

Must Read

Popular Articles